| Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches NH Goradel, N Mohajel, ZV Malekshahi, S Jahangiri, M Najafi, B Farhood, ... Journal of cellular physiology 234 (6), 8636-8646, 2019 | 81 | 2019 |
| Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease MA Khosravi, M Abbasalipour, JP Concordet, J Vom Berg, S Zeinali, ... European journal of pharmacology 854, 398-405, 2019 | 76 | 2019 |
| Oncolytic virotherapy: Challenges and solutions NH Goradel, AT Baker, A Arashkia, N Ebrahimi, S Ghorghanlu, ... Current problems in cancer 45 (1), 100639, 2021 | 75 | 2021 |
| SARS-CoV-2 spike (S) protein based vaccine candidates: state of the art and future prospects A Arashkia, S Jalilvand, N Mohajel, A Afchangi, K Azadmanesh, ... Reviews in Medical Virology, 2020 | 66* | 2020 |
| The inclusive review on SARS-CoV-2 biology, epidemiology, diagnosis, and potential management options A Beig Parikhani, M Bazaz, H Bamehr, S Fereshteh, S Amiri, ... Current microbiology 78, 1099-1114, 2021 | 60 | 2021 |
| T cell engineered with a novel nanobody‐based chimeric antigen receptor against VEGFR2 as a candidate for tumor immunotherapy F Hajari Taheri, M Hassani, Z Sharifzadeh, M Behdani, A Arashkia, ... Iubmb Life 71 (9), 1259-1267, 2019 | 53 | 2019 |
| Shedding light on the EpCAM: an overview SM Yahyazadeh Mashhadi, M Kazemimanesh, A Arashkia, ... Journal of cellular physiology 234 (8), 12569-12580, 2019 | 48 | 2019 |
| Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancer M Hassani, F Hajari Taheri, Z Sharifzadeh, A Arashkia, J Hadjati, ... Journal of Cellular Biochemistry 120 (6), 10787-10795, 2019 | 41 | 2019 |
| Polytope DNA vaccine development against hepatitis C virus: a streamlined approach from in silico design to in vitro and primary in vivo analyses in BALB/c mice A Memarnejadian, F Roohvand, A Arashkia, S Rafati, MA Shokrgozar Protein and peptide letters 16 (7), 842-850, 2009 | 30 | 2009 |
| Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c mice A Arashkia, F Roohvand, A Memarnejadian, MR Aghasadeghi, S Rafati Virus genes 40, 44-52, 2010 | 28 | 2010 |
| Strategies for enhancing intratumoral spread of oncolytic adenoviruses NH Goradel, B Negahdari, S Ghorghanlu, S Jahangiri, A Arashkia Pharmacology & therapeutics 213, 107586, 2020 | 23 | 2020 |
| The evolving direct and indirect platforms for the detection of SARS-CoV-2 SF Karkan, RM Baladi, M Shahgolzari, M Gholizadeh, F Shayegh, ... Journal of Virological Methods 300, 114381, 2022 | 19 | 2022 |
| Virus against virus: strategies for using adenovirus vectors in the treatment of HPV-induced cervical cancer M Ghanaat, NH Goradel, A Arashkia, N Ebrahimi, S Ghorghanlu, ... Acta Pharmacologica Sinica 42 (12), 1981-1990, 2021 | 19 | 2021 |
| Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses NH Goradel, A Alizadeh, S Hosseinzadeh, M Taghipour, Z Ghesmati, ... Future Oncology 18 (2), 245-259, 2021 | 19 | 2021 |
| Engineered jurkat cells for targeting prostate-specific membrane antigen on prostate cancer cells by nanobody-based chimeric antigen receptor M Hassani, FH Taheri, Z Sharifzadeh, A Arashkia, J Hadjati, ... Iranian biomedical journal 24 (2), 81, 2020 | 18 | 2020 |
| Differential maturation of miR-17~ 92 cluster members in human cancer cell lines M Abasi, F Kohram, P Fallah, A Arashkia, M Soleimani, N Zarghami, ... Applied biochemistry and biotechnology 182, 1540-1547, 2017 | 18 | 2017 |
| VP7 and VP4 genotypes of rotaviruses cocirculating in Iran, 2015 to 2017: Comparison with cogent sequences of Rotarix and RotaTeq vaccine strains before their use for universal … M Motamedi‐Rad, M Farahmand, A Arashkia, S Jalilvand, Z Shoja Journal of medical virology 92 (8), 1110-1123, 2020 | 17 | 2020 |
| Molecular analysis of human adenoviruses in hospitalized children< 5 years old with acute gastroenteritis in Tehran, Iran A Arashkia, F Bahrami, M Farsi, B Nejati, S Jalilvand, A Nateghian, ... Journal of medical virology 91 (11), 1930-1936, 2019 | 17 | 2019 |
| Prevalence and genetic diversity of norovirus genogroup II in children less than 5 years of age with acute gastroenteritis in Tehran, Iran M Farsi, F Roodbari, B Nejati, A Arashkia, S Jalilvand, A Nateghian, ... Medical microbiology and immunology 207, 201-210, 2018 | 17 | 2018 |
| Co‐administration of 2’3’-cGAMP STING activator and CpG-C adjuvants with a mutated form of HPV 16 E7 protein leads to tumor growth inhibition in the mouse model F Dorostkar, A Arashkia, F Roohvand, Z Shoja, M Navari, ... Infectious Agents and Cancer 16, 1-10, 2021 | 16 | 2021 |
Kayhan AzadmaneshPasteur Institute of IranVerified email at pasteur.ac.ir
